N-(2,2-Diphenylethyl)-2-(6-methoxynaphthalen-2-yl)propanamide

Abstract

N-(2,2-Diphenylethyl)-2-(6-methoxynaphthalen-2-yl)propanamide was prepared by a reaction between 2,2-diphenylethan-1-amine and naproxen in high yield. The newly obtained naproxen derivative was fully analyzed and characterized via ¹H, ¹³C, UV, IR, and mass spectral data.

1. Introduction

Naproxen 1 (Figure 1) is part of the aryl propionic family of non-steroidal anti-inflammatory drugs (NSAIDs). NSAIDs are commonly used worldwide. They can be either selective or non-selective cyclooxygenase (COX) inhibitors. Profens are considered one of the most important groups of non-selective COX inhibitors used in the treatment of inflammation associated with tissue injury [1].

2,2-diphenylethylamine 2 (Figure 1) is a fragment present in the structure of many naturally occurring compounds. Cherylline, latifine, and nomifensine (Figure 2) are representatives of alkaloids that contain 2,2-diphenylethan-1-amine in their structures. They represent very rare natural 4-aryl-1,2,3,4-tetrahydroisoquinoline alkaloids which are of interest because of their broad spectrum of biological activities. Representatives of 4-aryl-1,2,3,4-tetrahydroisoquinoline alkaloids exhibit broad spectrum of biological activities as: antagonistic [2], antibacterial [3], antiplasmodial [4], estrogen agonist/antagonist [5], and serotonin (5-HT) re-uptake [6].

Due to the importance of amides in the pharmaceutical synthesis [7,8], a coupling between naproxen and 2,2-diphenylethylamine via amide bond formation was achieved in order to obtain N-(2,2-diphenylethyl)-2-(6-methoxynaphthalen-2-yl)propanamide 3.

2. Results

Herein, we report the successfully synthesized N-(2,2-diphenylethyl)-2-(6-methoxynaphthalen-2-yl)propanamide 3, as shown in Scheme 1.

An easy and handy synthetic procedure for amide synthesis is the N,N′-dicyclohexylcarbodiimide (DCC)-mediated coupling between carboxylic acids and amines. DCC is used for the preparation of esters, amides, or anhydrides. DCC reacts with the carboxyl group of naproxen to produce an activated acylating agent that reacts with the amino group of the other molecule to form an amide bond.

The resultant compound is characterized by its melting point, ¹H and ¹³C-NMR, UV, IR, and HRMS spectra.

3. Materials and Methods

All reagents and chemicals were purchased from commercial sources (Sigma-Aldrich S.A. and Riedel-de Haën, Sofia, Bulgaria) and used as received. Melting points were determined on a Boetius hot stage apparatus and are uncorrected. The NMR spectral data were recorded on a Bruker Avance II +600 spectrometer (BAS-IOCCP—Sofia, Bruker, Billerica, MA, USA). ¹H-NMR and ¹³C-NMR spectra for compound 3 were taken in DMSO-d₆ at 600 MHz and at 150.9 MHz, respectively. Chemical shifts are given in relative ppm and were referenced to tetramethylsilane (TMS) (δ = 0.00 ppm) as an internal standard; the coupling constants are indicated in Hz. The NMR spectra were recorded at room temperature (ac. 295 K). Mass analyses were carried out on a Q Exactive Plus mass spectrometer (Thermo Fisher Scientific, Waltham, MA, USA). TLC was carried out on precoated 0.2 mm Fluka silica gel 60 plates (Merck KGaA, Darmstadt, Germany).

Synthesis of N-(2,2-Diphenylethyl)-2-(6-methoxynaphthalen-2-yl)propanamide 3

N,N’-Dicyclohexylcarbodiimide (1 mmol, 0.206 g) was added to a solution of naproxen (1 mmol, 0.230 g) in CH₂Cl₂. The reaction mixture was stirred at room temperature for 10 min. After the addition of 2,2-diphenylethylamine (1 mmol, 0.197 g), the reaction mixture was stirred for 50 min and the formation of white crystalline dicyclohexylurea was observed and then separated by filtration over a sintered glass filter. The filtrate was washed with a diluted hydrochloric acid, a saturated solution of Na₂CO₃, and brine. The combined organic layers were dried over anhydrous Na₂SO₄, and the solvent was removed under reduced pressure. The compound was purified by column chromatography (silica gel 60, 70–230 mesh, Merck; diethyl ether: petroleum ether = 1:1 (v/v).

N-(2,2-Diphenylethyl)-2-(6-methoxynaphthalen-2-yl)propanamide (3): white solid (m.p. 110–112 °C), yield 89% (0.364 g), ¹H-NMR (600 MHz, DMSO) δ 8.03 (t, J = 5.7 Hz, 1H), 7.72 (d, J = 9.0 Hz, 1H), 7.67 (d, J = 8.5 Hz, 1H), 7.59 (s, 1H), 7.27–7.25 (m, 2H), 7.23 (d, J = 4.4 Hz, 4H), 7.20–7.12 (m, 7H), 4.15 (t, J = 7.9 Hz, 1H), 3.86 (s, 3H), 3.74–3.68 (m, 1H), 3.67–3.60 (m, 2H), 1.30 (d, J = 7.0 Hz, 3H). ¹³C-NMR (151 MHz, DMSO) δ 173.88 (C=O), 157.39 (Ar, C-O-CH₃), 143.30 (C, Ar), 137.63(C, Ar), 133.53 (C, Ar), 129.57 (C, Ar), 128.81 (C, Ar), 128.73 (C, Ar), 128.39 (C, Ar), 128.33 (C, Ar), 126.93 (C, Ar), 126.73 (C, Ar), 125.66 (C, Ar), 118.93 (C, Ar), 106.07 (C, Ar), 55.59 (-OCH₃), 50.34 ((Ph)₂CH), 45.18 (CH₂), 43.73 (CH), 18.70 (CH-CH₃). UV λ_max, MeOH: 241 (ε = 12,500) nm. HRMS Electrospray ionization (ESI) m/z calcd for C₂₈H₂₈NO₂⁺ = 410.2115, found 410.2119 (mass error Δm = 0.98 ppm). IR(KBr) ν_max, cm⁻¹: 3364 ν(N-H), 3058, 3033 ν(C_sp²-H), 2996 ν_as(C_sp³-H, >CH₂), 2882 ν_s(C_sp³-H, > CH₂), 1655 _ν(C=O), 1603 ν(C=C, Ph), 1533 δ(N-H) + ν(C-N), 1503 ν(C=C, Ph), 1481 δ_s(>CH₂) and ν(C=C, Ph), 1457 ν(C=C, Ph), δ_as(CH₃), δ(N-CH₂), 1446, 1391, 1362 δ_s(CH₃), 1342 δ_s(-CH<), 1271, 1260 ν(Ph-NH), 1228 ν(HN-C=O), 1208, 1189, 1162 ν(C-N), 1121, 1090, 1067, 1052, 1028, 928, 893, 853 γ(C_sp²-H), 816 γ(C_sp²-H), 755, 732 γ(C_sp²-H), 696, 670, 640, 583, 473, 428 δ(C-N-C).

Copies of all spectra and ESI-HRMS (Figures S1–S5) are provided in the Supplementary Materials file.